InMode (NASDAQ:INMD – Get Free Report) and Jushi (OTCMKTS:JUSHF – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, risk, earnings, profitability, valuation, analyst recommendations and institutional ownership.
Analyst Ratings
This is a breakdown of recent recommendations and price targets for InMode and Jushi, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| InMode | 1 | 8 | 1 | 0 | 2.00 |
| Jushi | 0 | 0 | 0 | 1 | 4.00 |
InMode currently has a consensus target price of $16.60, suggesting a potential upside of 18.15%. Given InMode’s higher possible upside, equities research analysts clearly believe InMode is more favorable than Jushi.
Valuation & Earnings
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| InMode | $394.82 million | 2.25 | $181.27 million | $2.16 | 6.50 |
| Jushi | $257.52 million | 0.45 | -$48.78 million | ($0.33) | -1.80 |
InMode has higher revenue and earnings than Jushi. Jushi is trading at a lower price-to-earnings ratio than InMode, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares InMode and Jushi’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| InMode | 41.04% | 14.50% | 12.88% |
| Jushi | -25.15% | N/A | -15.07% |
Risk & Volatility
InMode has a beta of 2.13, suggesting that its share price is 113% more volatile than the S&P 500. Comparatively, Jushi has a beta of -1.02, suggesting that its share price is 202% less volatile than the S&P 500.
Insider and Institutional Ownership
68.0% of InMode shares are owned by institutional investors. Comparatively, 21.7% of Jushi shares are owned by institutional investors. 6.9% of InMode shares are owned by company insiders. Comparatively, 22.5% of Jushi shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Summary
InMode beats Jushi on 12 of the 15 factors compared between the two stocks.
About InMode
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.
About Jushi
Jushi Holdings Inc., a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for medical and adult-use markets. The company offers flower, extracts, concentrates, edibles, oil, pre-rolls, tinctures, capsules, softgels, cannabis-infused gummies and ultra-premium chocolate, and topicals products, as well as vaporization devices and cartridges under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands. It is also involved in the bulk wholesale of refined cannabinoids and terpenes. In addition, the company operates medical cannabis dispensaries under the BEYOND/HELLO, Nature’s Remedy, and NuLeaf brands. It markets its products to local dispensaries and large multi-state operators. The company is headquartered in Boca Raton, Florida.
Receive News & Ratings for InMode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InMode and related companies with MarketBeat.com's FREE daily email newsletter.
